All In Biotech

Drug Trial Radar · NCT04996875

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

A Phase 2 Open-Label, Multicenter Clinical Study of the Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Profiles of CGT9486 as a Single Agent in Patients With Advanced Systemic Mastocytosis

Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

140

Planned (sponsor's estimate)

Start

Nov 9, 2021

Primary completion

Sep 19, 2025

Study completion Jul 2027

Sponsor

Lead sponsor
Cogent Biosciences, Inc.Industry
Sponsor type
Industry
First posted
Aug 9, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL).

Conditions

  • Advanced Systemic Mastocytosis (AdvSM)
  • SM With an Associated Hematologic Neoplasm (SM-AHN)
  • Mast Cell Leukemia (MCL)
  • Aggressive Systemic Mastocytosis (ASM)

Interventions

  • bezuclastinibDrug

    Bezuclastinib is administered as tablets to be taken orally, continuously in 28-day cycles.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part I: Identify clinically active and tolerable exposures of bezuclastinib in patients with AdvSMTime frame: 18 months
  2. Part II: - Determine efficacy of bezuclastinib as measured by mIWG Objective Response Rate (ORR) - Confirm the exposure-response relationship of bezuclastinibTime frame: 18 months

Locations

42 sites in 14 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham (UAB) Hospital

    Birmingham, Alabama · Active not recruiting

  • Mayo Clinic Arizona

    Phoenix, Arizona · Recruiting

  • City of Hope Comprehensive Cancer Center

    Duarte, California · Recruiting

  • UCLA Medical Center

    Los Angeles, California · Recruiting

  • Stanford Cancer Institute

    Stanford, California · Recruiting

  • Galiz Research

    Hialeah, Florida · Withdrawn

  • Winship Cancer Institute - Emory University

    Atlanta, Georgia · Recruiting

  • Rush University Medical Center

    Chicago, Illinois · Withdrawn

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Columbia University Irving Medical Center

    New York, New York · Withdrawn

  • Cleveland Clinic Taussig Cancer Center

    Cleveland, Ohio · Active not recruiting

  • MUSC Health University Medical Center

    Charleston, South Carolina · Recruiting

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Huntsman Cancer Institute - University of Utah Health

    Salt Lake City, Utah · Recruiting

  • Nepean Hospital

    Kingswood, New South Wales, Australia · Recruiting

  • Gold Coast University Hospital

    Southport, Queensland, Australia · Recruiting

  • Peter MacCallum Cancer Centre

    Melbourne N., Victoria, Australia · Recruiting

  • AKH Wien, Universitatsklinikum

    Vienna, Austria · Active not recruiting

  • CHU de Liege

    Liège, Belgium · Withdrawn

  • University of Alberta Hospital

    Edmonton, Alberta, Canada · Recruiting

  • St. Michael's Hospital - Unity Health Toronto

    Toronto, Ontario, Canada · Recruiting

  • Necker-Enfants Malades Hospital

    Paris, France · Active not recruiting

  • Centre Hospitalier Universitaire (CHU) de Poitiers

    Poitiers, France · Active not recruiting

  • Centre Hospitalier Universitaire (CHU) de Toulouse

    Toulouse, France · Active not recruiting

  • University Hospital Aachen

    Aachen, Germany · Active not recruiting

  • Universitätsklinikum Freiburg

    Freiburg im Breisgau, Germany · Active not recruiting

  • UKSH Campus Lubeck

    Lübeck, Germany · Withdrawn

  • Universitätsklinikum Mannheim

    Mannheim, Germany · Active not recruiting

  • IRCCS Azienda Ospedaliero Universitaria di Bologna

    Bologna, Italy · Terminated

  • Azienda Ospedaliero Universitaria Careggi

    Florence, Italy · Withdrawn

  • AOU San Giovanni di Dio e Ruggi dAragonia

    Salerno, Italy · Active not recruiting

  • Azienda Ospidaleira Universitaria Integrata Verona

    Verona, Italy · Withdrawn

  • University Medical Center Groningen

    Groningen, Netherlands · Active not recruiting

  • Oslo University Hospital

    Oslo, Norway · Active not recruiting

  • Public University Hospital No. 1 in Lublin

    Lublin, Poland · Active not recruiting

  • Hospital Universitario Vall d'Hebron

    Barcelona, Spain · Active not recruiting

  • Institut Català d'Oncologia - Hospital Duran i Reynals

    Barcelona, Spain · Active not recruiting

  • Hospital Universitario Ramón y Cajal

    Madrid, Spain · Active not recruiting

  • Universitätsspital Basel

    Basel, Switzerland · Recruiting

  • Leeds Teaching Hospitals NHS Trust

    Leeds, United Kingdom · Recruiting

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.